AGP Executive Report
Last update: 8 hours agoStroke Care Upgrade: Taiwan launched a pilot inpatient rehabilitation program for stroke patients, offering up to 180 days of intensive daily therapy (2–5 hours) at 10 NHI-participating hospitals, aiming to serve 1,600–2,000 patients a year with NT$300 million in extra funding. Public Health Research: A Stanford observational study reported estrogen-only menopausal hormone therapy is linked with lower odds of Alzheimer’s disease neuropathologic change and clinician-defined dementia, while noting it isn’t proof of causation. Medical Safety & Access: Taiwan’s TFDA ordered a recall of more than 87,000 antihypertensive tablets, underscoring ongoing drug quality controls. Care for the Vulnerable: Taiwan’s Constitutional Court ruled old statute-of-limitations rules for child sexual assault unconstitutional and ordered retrials for 11 victims. Health Tech & Monitoring: A review from Hebei Medical University examined prolonged disorders of consciousness management, focusing on electrical signal recordings and their limits. Wellness for Screens: A wellness piece highlights blue light blocking glasses as a practical aid for evening screen users, with better sleep support via melatonin protection. Health System Capacity: Taiwan ICDF marked 30 years by expanding from traditional healthcare aid into smart healthcare and digital transformation partnerships.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
